Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Rises By 116.0%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 52,500 shares, an increase of 116.0% from the October 15th total of 24,300 shares. Based on an average daily volume of 109,800 shares, the short-interest ratio is currently 0.5 days.

Tevogen Bio Price Performance

NASDAQ TVGNW remained flat at $0.06 during trading on Friday. The company’s stock had a trading volume of 29,036 shares, compared to its average volume of 66,513. Tevogen Bio has a 12 month low of $0.01 and a 12 month high of $0.28. The stock has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.03.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.